Psychemedics Corp
NASDAQ:PMD
Psychemedics Corp
NASDAQ:PMD
Price:
2.53 USD
-0.39%
Market Closed
Updated:
May 8, 2024
Psychemedics Corp
Research & Development
|
Psychemedics Corp
Research & Development Peer Comparison
Comparables:
DVA
DGX
CVS
CI
LH
Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Psychemedics Corp
NASDAQ:PMD
|
Research & Development
-$1.1m
|
CAGR 3-Years
4%
|
CAGR 5-Years
6%
|
CAGR 10-Years
-3%
|
|
|
DaVita Inc
NYSE:DVA
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
CVS Health Corp
NYSE:CVS
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Cigna Corp
NYSE:CI
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Psychemedics Corp's Research & Development?
Research & Development
-1.1m
USD
-1.1m
USD
Based on the financial report for Dec 31, 2023, Psychemedics Corp's Research & Development amounts to -1.1m USD.
What is Psychemedics Corp's Research & Development growth rate?
Research & Development CAGR 10Y
-3%
-3%
Over the last year, the Research & Development growth was 14%. The average annual Research & Development growth rates for Psychemedics Corp have been 4% over the past three years , 6% over the past five years , and -3% over the past ten years .
You don't have any saved screeners yet
